Analysis service for causes of drop in AI search for pharmaceuticals.
"Safety" and "evidence" do not reach AI. A technical assessment for pharmaceutical-related sites to be correctly cited in AI searches.
The proliferation of generative AI and AI search has dramatically changed the information-gathering processes for researchers and procurement professionals. However, in the pharmaceutical and life sciences sectors, there is a risk of being overlooked as candidates for comparison or having strengths misunderstood due to a "structure in which AI cannot accurately interpret specialized information," despite possessing advanced technologies, clinical trial data, and quality control systems. This service analyzes your website based on the logic of "AI evaluating the reliability of information (E-E-A-T) and generating expert responses." It visualizes where information gaps occur and why they do not lead to nominations or inquiries, prioritized for improvement. ▼ Are you facing these issues? - When searching for "specific compounds or formulation technologies," competitors are recommended first. - High-level evidence is buried within PDFs and is not cited or summarized by AI. - AI responses remain at a general explanatory level, failing to convey your unique advantages. - You want to ensure AI recognizes your information correctly while maintaining compliance with regulations like the Pharmaceutical and Medical Device Act. Why not achieve both "accuracy and accessibility of information"? If you share your current URL, we can quickly organize the points where your website is "losing out in AI search" and guide you on how to proceed with the diagnosis.
- Company:アンドワン 本社、東京支社、川崎営業所
- Price:Other